Feb 24, 2026, 06:54 by

ClearNote Health announced an enhanced Avantect® Pancreatic Cancer Test, which delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5% for patients at elevated risk of this disease.

Feb 24, 2026, 02:48 by User Not Found

Clinical Research News | Ensuring that patients who participate in clinical trials are the ones who bear the burden of the disease is a major and well-recognized challenge due to barriers ranging from mistrust of research and science to lack of access to clinical trials and cultural and logistical barriers.

Feb 19, 2026, 01:00 by User Not Found

Clinical Research News | Life sciences executives remain cautiously optimistic about 2026, but a striking geographic divide has emerged that reveals growing concerns about U.S. regulatory and pricing policies, according to Deloitte Consulting’s 2026 Life Sciences Executive Outlook. Andy Bolt, leader of the firm’s Life Sciences R&D Practice, presented the data earlier this month at the Clinical Trial Venture, Innovation, and Partnering event with SCOPE.

Feb 18, 2026, 20:48 by

Feb 18, 2026, 20:48 by

Feb 17, 2026, 08:01 by

Feb 17, 2026, 01:01 by User Not Found

Clinical Research News | A top scientific leader at Merck issued a call to action to stakeholders in the clinical research enterprise at last week’s SCOPE event, inviting them to focus on what’s important to the real-world people they’re looking to treat and clearly answering the questions being asked by people holding anti-science views.

Feb 13, 2026, 09:06 by User Not Found

Clinical Research News | At the recent SCOPE Venture, Innovation, and Partnering Conference in Orlando, healthcare veteran Carolyn Magill, Venture Partner at Defined Ventures, sat down with Sunny Kumar, Partner at Informed Ventures, to discuss a pressing question facing the pharmaceutical industry: How can pharma harness the transformative power of artificial intelligence while navigating its traditionally risk-averse culture?

Feb 12, 2026, 01:01 by User Not Found

Clinical Research News | Clinical trials have always struggled with the problematic trio: study execution, patient recruitment, and engagement. In the newest episode of The Scope of Things, Joseph Kim, chief strategy officer of ProofPilot, spoke about the reason why these problems have still not been solved, despite repeated attempts.

Feb 11, 2026, 08:32 by

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services company, have signed a Memorandum of Understanding (MOU) to collaborate on multinational clinical trial services.

Feb 11, 2026, 01:00 by User Not Found

Clinical Research News | Clinical research in amyotrophic lateral sclerosis has long been hindered by subjective endpoints, slow enrollment, and limited tools for tracking disease progression. EverythingALS, a nonprofit initiative, is addressing those barriers with a speech-based digital biomarker designed to modernize how ALS trials are conducted and evaluated.

Feb 10, 2026, 08:09 by User Not Found

Clinical Research News | The promise of AI was on full display at last week’s SCOPE event in Orlando, peppering each of hundreds of presentations focused on the future of clinical research. Analysts have projected that AI in clinical trials will represent an $8 billion business segment by 2030, generating up to $110 billion per year in value to pharma, but that will not happen unless the workflows are redesigned.

Feb 9, 2026, 07:43 by

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.

Feb 9, 2026, 07:43 by

Feb 5, 2026, 01:00 by User Not Found

Clinical Research News | SCOPE 2026 kicked off in Orlando this week honoring XX groups with awards recognizing their technical innovations and creative work in service of patients and sites. The honored groups were Biogen, Proximity Health Solutions, TrialScreen, The Association of Multisite Research Corporations (AMRC), and new product awards for Biorce, ZigZag, Medidata, Innovative Trials, and Anju.

Feb 4, 2026, 07:51 by

Cirena has announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.

Feb 3, 2026, 17:42 by User Not Found

Clinical Research News | ORLANDO—For patients with a rare disease participating in clinical trials, hope can be a “doubled-edged sword,” potentially saving their lives but also burdening them with enormous, if unintended, hidden costs. Hope is also their “trust in us” as they desperately search for restorative treatments like chimeric antigen receptor (CAR) T-cell therapy, Jane Myles told a packed house during the opening day plenary keynote address at this week’s SCOPE event in Orlando.

Feb 3, 2026, 01:00 by User Not Found

Clinical Research News | An assortment of new product launches, funding news, and leadership appointments were announced in conjunction with this week’s SCOPE event in Orlando, which is experiencing a record-breaking attendance exceeding 4,800 people. The announcements serve as a potent reminder that artificial intelligence is having a field day in clinical research, and the common aim is right sizing the time and cost of getting medicines to market.

Feb 2, 2026, 13:23 by User Not Found

Clinical Research News | SCOPE is kicking off this week and among all of the other events, speakers, and awards programs planned, the Best of Show awards again brings an impressive docket of new products to the SCOPE exhibit hall floor with a record-breaking 70 new products on display in Orlando.

Jan 30, 2026, 08:43 by